JPS6148504B2 - - Google Patents

Info

Publication number
JPS6148504B2
JPS6148504B2 JP52097095A JP9709577A JPS6148504B2 JP S6148504 B2 JPS6148504 B2 JP S6148504B2 JP 52097095 A JP52097095 A JP 52097095A JP 9709577 A JP9709577 A JP 9709577A JP S6148504 B2 JPS6148504 B2 JP S6148504B2
Authority
JP
Japan
Prior art keywords
formula
trinor
oxa
didehydro
phenylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52097095A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5323967A (en
Inventor
Reonaado Bandei Goodon
Chaaruzu Piitaason Debitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/810,811 external-priority patent/US4112224A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS5323967A publication Critical patent/JPS5323967A/ja
Publication of JPS6148504B2 publication Critical patent/JPS6148504B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP9709577A 1976-08-16 1977-08-15 Composition and method Granted JPS5323967A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71439076A 1976-08-16 1976-08-16
US05/810,811 US4112224A (en) 1976-08-16 1977-06-30 Biheterocyclic-9,11-trideoxy-PGF compounds

Publications (2)

Publication Number Publication Date
JPS5323967A JPS5323967A (en) 1978-03-06
JPS6148504B2 true JPS6148504B2 (en, 2012) 1986-10-24

Family

ID=27109143

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9709577A Granted JPS5323967A (en) 1976-08-16 1977-08-15 Composition and method

Country Status (8)

Country Link
JP (1) JPS5323967A (en, 2012)
AU (1) AU505149B2 (en, 2012)
CH (2) CH632252A5 (en, 2012)
DE (1) DE2736782A1 (en, 2012)
FR (1) FR2362130A1 (en, 2012)
GB (1) GB1540049A (en, 2012)
HU (1) HU180103B (en, 2012)
NL (1) NL7708963A (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100192A (en) * 1977-04-18 1978-07-11 The Upjohn Company Inter-phenylene-PG amides
JPS5925443A (ja) * 1982-08-02 1984-02-09 Mitsubishi Electric Corp レ−ダ受信機の校正方法
US5213388A (en) * 1991-09-30 1993-05-25 Baker Franklin W Anti-theft vehicle seat apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950363A (en) * 1975-03-10 1976-04-13 The Upjohn Company Prostaglandin cyclic ethers

Also Published As

Publication number Publication date
FR2362130A1 (fr) 1978-03-17
HU180103B (en) 1983-01-28
FR2362130B1 (en, 2012) 1984-12-21
AU2729277A (en) 1979-02-01
GB1540049A (en) 1979-02-07
JPS5323967A (en) 1978-03-06
CH632252A5 (en) 1982-09-30
CH633543A5 (en) 1982-12-15
AU505149B2 (en) 1979-11-08
NL7708963A (nl) 1978-02-20
DE2736782A1 (de) 1978-02-23

Similar Documents

Publication Publication Date Title
US4116988A (en) 16-Phenoxy prostaglandin E1 analogs
US4112224A (en) Biheterocyclic-9,11-trideoxy-PGF compounds
JPH06145085A (ja) カルバサイクリン類似体類
JPS6029384B2 (ja) ４，５，６−トリノル−３，７−インタ−−ｍ−フエニレンＰＧＥ，化合物類
US4225508A (en) 19-Hydroxy-PGI2 compounds
US4238414A (en) 2-Decarboxy-2-aminomethyl-6a-carba-PGI2 compounds
JPH0355458B2 (en, 2012)
US4705806A (en) Prostacyclin analogs
US4225507A (en) 19-Hydroxy-19-methyl-PGI2 compounds
US4033989A (en) 9-Deoxy-PGF2 Analogs
JPS5929193B2 (ja) ４，４，５，５−テトラデヒドロｐｇｆ１
US4732914A (en) Prostacyclin analogs
US4028350A (en) 9α,11αOR 11α,9αEpoxymethano-prostaglandans and process for their preparation
JPS5829759A (ja) １１−デソキシ−１６−アリ−ルオキシ−ω−テトラノルプロスタグランジン類
US4361577A (en) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandins and process for their preparation
JPS6148504B2 (en, 2012)
US4338332A (en) Fluoro-prostaglandins
EP0086611A1 (en) 9-Substituted carbacyclin analogues
JPS5846510B2 (ja) １３，１４−デヒドロ−１１−デオキシ−プロスタグランジン及びその製造法
US4338316A (en) 9-Aryloxy prostane derivatives
US4048194A (en) 6α-Methoxy-4α-hydroxy-2β-hydroxymethyl-3.alpha.-tetrahydropyranacetic acid 4α γ-lactone ethers and acylates
US4084058A (en) 4,5,6-Trinor-3,7-inter-m-phenylene prostaglandin F1α analogs
EP0088619A2 (en) Benzopyrans
US4425359A (en) Fluoro-prostaglandins and process for their preparation
CA1085832A (en) Prostaglandin analogs